Founder & CEO of Phorix
Dr. Mark Lightowler is an exceptional strategic thinker, incredibly innovative and has a vision for the future of healthcare. His significant background and experience in pharma and healthcare allowed Dr. Lightowler to start his own company, Phorix Limited.
Through his work with Phorix Limited, Dr. Lightowler is working to become ‘The New Kind of Billionaire’. Learn more @ https://www.youtube.com/watch?v=yiT5LoY4ciM
Work Background
Before starting Phorix Limited, Dr. Mark Lightowler spent his time at Harvard Business School, University of Bath, Tuck School of Business at Dartmouth, and more, receiving degrees in Corporate Education, Strategic Communication, Negotiation, Finance, Chemistry, Behavioral Sciences and more. A very well-rounded education led Dr. Lightowler to work in Clinical Research at Merck Lipha Pharma, Head of Digital Solutions at Novartis, and a position of Deputy Head of Medical Affairs at Schering Plough, all before founding Phorix Limited.
Co-Creator, First Annual Digital Therapeutics Forum
Despite the incredible work Dr. Mark Lightowler is doing with his own organization, he took time out of his busy schedule to contribute to Pittsburgh’s First Annual Digital Therapeutics Forum back in May! The Echo Team would like to thank Dr. Lightowler for his dedication, passion for healthcare, and continuing to share his extensive knowledge with everyone around him!
About Phorix
‘Phorix is a design company that helps clients understand and change their customer’s behavior with innovation and communications’ They work to enhance customer engagement by creating different plans to change customer behavior and developing action plans that consumers will stick to.